Fluconazole for the treatment of cutaneous leishmaniasis [4] (multiple letters)

New England Journal of Medicine

Volumn 347, Issue 5, 2002, Pages 370-371

  Zvulunov, Alex ^a   Klaus, Sidney ^a   Vardy, Daniel ^a   Alrajhi, Abdulrahman A ^a   De Vol, Edward B ^a   Maguire, James H ^a  

^a Clalit Health Services   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; LESHCUTAN; PAROMOMYCIN;

DRUG COST; DRUG EFFICACY; HUMAN; LEISHMANIA MAJOR; LETTER; PRIORITY JOURNAL; SIDE EFFECT; SKIN DEFECT; SKIN LEISHMANIASIS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; ANTIPROTOZOAL AGENTS; FLUCONAZOLE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; PAROMOMYCIN;

EID: 0036682185     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200208013470517     Document Type: Letter

References (0)